California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk 
U.S. Suspends UK Technology Deal Amid Trade Disputes Under Trump Administration 
Sydney Bondi Beach Terror Attack Kills 16, Sparks Gun Law and Security Debate 
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman 
Belarus Frees Opposition Leaders Maria Kalesnikava and Viktar Babaryka in U.S.-Brokered Deal 
European Leaders Tie Ukraine Territorial Decisions to Strong Security Guarantees 
Thousands Protest in Brazil Against Efforts to Reduce Jair Bolsonaro’s Prison Sentence 
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now 
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
Lab-grown meat: you may find it icky, but it could drive forward medical research 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
A presentation on thimerosal, a mercury-based vaccine preservative, set to be delivered to the CDC’s advisory committee has come under scrutiny for referencing a non-existent study. The report, “Thimerosal as a Vaccine Preservative,” authored by Lyn Redwood—former leader of the anti-vaccine group Children’s Health Defense—cited a 2008 study allegedly co-authored by UC Davis Professor Emeritus Robert Berman. However, Berman confirmed that such a study was never conducted by him and said the cited findings misrepresented his actual research published in Toxicological Sciences.
The erroneous citation was first reported by Reuters, prompting the CDC to upload a revised version of Redwood’s presentation, removing the disputed slide. The controversy has intensified after Health Secretary Robert F. Kennedy Jr. recently replaced the CDC’s entire 17-member vaccine panel with eight new members, half of whom are known vaccine skeptics.
Both Republican Senator Bill Cassidy and Democratic Senator Patty Murray have urged postponement of the June 25–26 meeting, citing the panel’s lack of vetting and the absence of a CDC director. Redwood’s presentation contrasts with a separate CDC staff report reaffirming that thimerosal-containing vaccines do not cause autism or other neurodevelopmental issues.
According to CDC data, 96% of flu vaccines administered during the 2024–25 season were thimerosal-free, and only 0.3% of flu vaccines given to pregnant women contained the preservative. Kennedy, a long-time critic of vaccine safety, has previously claimed thimerosal causes brain damage—claims consistently debunked by scientific research.
The thimerosal debate highlights rising tensions around vaccine policy and misinformation, especially as newly appointed CDC advisors consider whether to recommend thimerosal-free vaccines for all pregnant women and children. Redwood has not yet responded to requests for comment.
